SCOTTSDALE, AZ, October 22, 2025 – CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced that it has been awarded a $3 million grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to determine if the presence of the protein phosphorylated alpha-synuclein (P-SYN) in patients with essential tremor (ET) predicts the likelihood of developing Parkinson’s disease (PD). The company’s Syn-One Test® will be studied as a predictive tool to help assess which patients may be at risk for developing PD. Outcomes from the “Syn-T Study” could have major implications for the treatment and management of people with ET in the future.Continue reading
Author Archive: AZBio
A Decade of Impact: U of A and Banner Health transform health care in Arizona
Collaboration delivers more than $59 billion in economic impact and statewide growth in patient care, research and opportunity.
GPN Vaccines Inc Completes Acquisition of BacVax Inc.
New York, USA – 24th October 2025 – GPN Vaccines Inc (“GPN”) is pleased to announce it has successfully completed the acquisition of BacVax Inc. (“BacVax”), a biotechnology company based in Phoenix, Arizona, that is developing vaccines targeting bacterial infections.Continue reading
U of A works to build a pediatric powerhouse with institute
College of Medicine – Phoenix’s Stewart Goldman and Vlad Kalinichenko have simple goal — make children’s lives better.
Continue reading
Breakthrough clinical trial confirms that GammaTile delivers superior tumor control compared to standard of care for patients with newly diagnosed operable brain metastases
Immediate, targeted radiation at the time of surgery reduces the risk of tumor recurrence or death by greater than 50% compared to standard of care in early clinical data readoutContinue reading
ASU’s new School of Medicine receives preliminary accreditation, gift and new name
PHOENIX, AZ — The opening of Arizona State University’s new medical school took a giant leap forward today with two important pieces of news that will accelerate activity as the school begins to prepare for its first class in August 2026.
ASU leaders announced that the school, the flagship of the university’s ASU Health system, received preliminary accreditation from the Liaison Committee on Medical Education (LCME), enabling the school to begin recruiting its first class of students. In addition, the university received a nine-figure gift, the second largest in university history, to establish and operate the new school, which now will be known as the John Shufeldt School of Medicine and Medical Engineering.Continue reading
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
FRANKLIN LAKES, N.J. — Oct. 09, 2025 — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the Rotarex™ Catheter System in the treatment of patients with peripheral artery disease (PAD) lesions.Continue reading
Taiwan AI Smart Health Showcase Center Established at Phoenix Bioscience Core
PHOENIX, Ariz. – To advance health care and biomedical opportunities between Arizona and Taiwan, the City of Phoenix, Arizona Commerce Authority, Arizona State University (ASU), and Taiwan Digital Health Industry Development Association signed a Declaration of Collaboration focused on establishing and promoting the Taiwan AI Smart Health Showcase Center on the Phoenix Bioscience Core (PBC) in downtown. The signing ceremony was held on Oct. 9 at Venture Cafe Phoenix in the 850 PBC Building, 850 N. 5th St.Continue reading